LAGUNA NIGUEL, Calif., May 26, 2015 /PRNewswire/ -- DiBari Group, a leading debt advisory firm in the venture capital and private equity markets, announced today its new name - Credo 180 Capital Partners. The new Credo 180 brand encapsulates the core value of 'Customer First' as the firm continues to expand its geographic presence and depth of its team. In addition, the firm announced Chad Norman has joined as Managing Partner. Chad will manage the firm's Northern California office and help expand its strategic relationships both in the US and abroad.
Mr. Norman joins Credo 180 from Hercules Technology Growth Capital, where he spent four years as a Managing Director in Life Sciences advising early stage companies on their capitalization strategies. Before that, he worked with Oxford Finance to build its East Coast market. At Oxford, he spent nearly a decade structuring senior debt capital financings for emerging growth biotech and medical device companies.
Norman said, "The Credo 180 team pioneered the debt-advisory business over 20 years ago. I have known and worked with the individuals involved there for a long time. I have been consistently impressed with the quality of work and insights they deliver for their clients. I am looking forward to sharing my firsthand experience as a lender in order to enhance that level of expertise and service."
Rob Winkelmann, Managing Partner & CEO of Credo 180 said, "I have personally worked alongside Chad as a fellow Lender and also through my capacity as an advisor. We are truly pleased to have his experience and stellar reputation as an entrusted figure in the life-science financing arena. The addition of Chad underscores our sincere commitment to providing only the most experienced and most accomplished debt financing professionals and the corresponding level of service required to support our investment partners and clients."
Mr. Norman graduated Summa Cum laude from NC State University and earned a Master's degree with honors from the London School of Economics. He is also a former combat medic in the US Army, where he was attached to the 312th Field Hospital in North Carolina.
SOURCE Credo 180 Capital Partners